Performance evaluation of a novel size-based microfluidic platform for rare cell detection in blood and malignant effusions
Background Circulating tumour cells (CTCs) are promising minimally invasive biomarkers of tumour dissemination and disease biology, but low abundance and phenotypic heterogeneity make them challenging to isolate, particularly in non-small cell lung cancer (NSCLC). Physical cell-selection approaches based on size and de...